Status:
TERMINATED
Two Dose Epidural Morphine for Post-cesarean Analgesia
Lead Sponsor:
Columbia University
Conditions:
Pain
Morphine Adverse Reaction
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonster...
Detailed Description
This will be a randomized, double-blinded placebo-controlled study. In this study, women who underwent cesarean section with epidural anesthesia will receive 3 mg of epidural morphine intraoperatively...
Eligibility Criteria
Inclusion
- Women undergoing cesarean section under epidural anesthesia.
Exclusion
- Emergent cesarean section
- Coagulopathy
- Failed epidural anesthesia or patchy block
- General anesthesia
- Use of epidural chloroprocaine
- Allergy or contraindication to Non-steroidal anti-inflammatory drug (NSAIDs)
- Severe opioid side effects
- History of chronic opioid use
- History of chronic pain
- History of obstructive sleep apnea
- Morbid obesity (Body Mass Index (BMI)\>45 kg/m2)
- Height under 4' 10" (147 cm)
- Documented dural puncture by the epidural (Tuohy) needle
- Preeclampsia
- Other significant medical disease (American Society of Anesthesiologists (ASA) 3 or more).
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01844206
Start Date
June 1 2013
End Date
June 1 2014
Last Update
December 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian Hospital
New York, New York, United States, 10032